The invention provides compounds of Formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
US8541441B2
申请人:——
公开号:US8541441B2
公开(公告)日:2013-09-24
[EN] SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS SÉLECTIFS DES GLYCOSIDASES ET LEURS UTILISATIONS
申请人:UNIV FRASER SIMON
公开号:WO2010012106A1
公开(公告)日:2010-02-04
The invention provides compounds of Formula (I) for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating diseases and disorders related to deficiency or overexpression of O-GlcNAcase, accumulation or deficiency of O-GlcNAc.
The chemistry of castanospermine, part I: synthetic modifications at C-6
作者:Richard H. Furneaux、Graeme J. Gainsford、Jennifer M. Manson、Peter C. Tyler
DOI:10.1016/s0040-4020(01)85075-4
日期:1994.2
Methodology for the selective functionalisation of castanospermine is outlined which has allowed the synthesis of a number of analogues selectively modified at C-6. Australine and some australine analogues have also been synthesized from castanospermine.